Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00598689 · ClinicalTrials.gov registry record · Phase 4
GenTeal in Perioperative Treatment of Laser Assisted in Situ Keratomileusis LASIK Patients
A Phase 4 study of Corneal Epithelium Defect, sponsored by Augusta University.
- Completed
- Registry status
- Phase 4
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT00598689 is a Phase 4 study of Corneal Epithelium Defect that has completed, run by Augusta University. The registered enrollment target is 80 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00598689, a Phase 4 study of Corneal Epithelium Defect, has completed, sponsored by Augusta University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
GenTeal gel is an artificial tear gel used to lubricate the surface of the eye. This study will evaluate the effect of GenTeal gel on comfort following LASIK surgery. Participants will be asked to come to the clinic for three regularly scheduled visits after LASIK surgery: Day 1 (one day after LASIK surgery), Day 7 (one week follow-up), and Day 30 (one month follow-up). Participants will be asked to complete a questionnaire regarding eye comfort during each follow up visit. Participants will be randomly assigned to one of two groups, one of which will receive Genteal Gel four times a day for five days prior to surgery. The other group will receive no preoperative gel or lubricant, which has been our standard approach for many years.
Conditions Studied
Interventions
- DRUG 0.3% hypromellose
Study Locations (1)
Georgia
- EyeCare One - Augusta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2007-10 |
| Est. Completion | 2009-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00598689
The ClinicalTrials.gov registry entry for NCT00598689 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Augusta University, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Corneal Epithelium Defect appearing as the primary indexed condition, and to 1 intervention - of which 0.3% hypromellose is the first listed.
NCT00598689 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT00598689 about?
NCT00598689 is a clinical study titled "GenTeal in Perioperative Treatment of Laser Assisted in Situ Keratomileusis LASIK Patients". GenTeal gel is an artificial tear gel used to lubricate the surface of the eye. This study will evaluate the effect of GenTeal gel on comfort following LASIK surgery. Participants will be asked to come to the clinic for three regularly scheduled visits after LASIK surgery: Day 1 (one day after LASIK...
What is the current status of trial NCT00598689?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 2007-10. Estimated completion is 2009-10.
What conditions does trial NCT00598689 study?
This clinical trial studies the following conditions: Corneal Epithelium Defect.
What interventions are being tested in trial NCT00598689?
The interventions under investigation include: 0.3% hypromellose (DRUG).
Who is sponsoring clinical trial NCT00598689?
This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00598689 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.